N-(4-Hydroxyphenyl)benzenesulfonamide, 99.0%, 250mg

(S)-1-METHOXY-2-PROPYLAMINE, 95%, 1g

2,2'-Biphenyldimethanol, 95.0%, 5g

2-Fluoro-6-methylaniline, 98.0%, 100g

(2E)-1-(2,4-dimethylphenyl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one, 95.0%, 10g

4-nitrophenyl 2-(pyridin-2-yldisulfanyl)ethyl carbonate, 95.0%, 1g

Tetrasodium pyrophosphate Anhydrous, 250g

1-(3-BROMOPYRIDIN-2-YL)CYCLOPROPANECARBONITRILE, 95.0%, 1g

Methyl 4-(((benzyloxy)carbonyl)amino)bicyclo[2.2.1]heptane-1-carboxylate, 98%, 100mg

2-((tert-Butoxycarbonyl)amino)-2-phenylacetic acid, 95.0%, 1g

Fmoc-(R)-3-amino-3-(2-nitrophenyl)propionic acid, 97%, 5g

LETERMOVIR, 95%, 100mg

Vinylmethylsiloxane-dimethylsiloxane copolymer, trimethylsiloxy terminated cSt 250-350, 100g